The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
TGR5-Mediated Bile Acid Sensing Controls Glucose Homeostasis
Open accessAbstract
TGR5 is a G protein-coupled receptor expressed in brown adipose tissue and muscle, where its activation by bile acids triggers an increase in energy expenditure and attenuates diet-induced obesity. Using a combination of pharmacological and genetic gain- and loss-of-function studies in vivo, we show here that TGR5 signaling induces intestinal glucagon-like peptide-1 (GLP-1) release, leading to improved liver and pancreatic function and enhanced glucose tolerance in obese mice. In addition, we show that the induction of GLP-1 release in enteroendocrine cells by 6alpha-ethyl-23(S)-methyl-cholic acid (EMCA, INT-777), a specific TGR5 agonist, is linked to an increase of the intracellular ATP/ADP ratio and a subsequent rise in intracellular calcium mobilization. Altogether, these data show that the TGR5 signaling pathway is critical in regulating intestinal GLP-1 secretion in vivo, and suggest that pharmacological targeting of TGR5 may constitute a promising incretin-based strategy for the treatment of diabesity and associated metabolic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Bacteria-derived secondary bile acids (lithocholic acid, deoxycholic acid) can activate the G-protein coupled bile acid receptor Gpbar1 receptor (TGR5) in L cells, promoting the peripheral release of GLP-1 and PYY (Katsuma et al., 2005;Thomas et al., 2009;Ullmer et al., 2013).”
From The Microbiota-Gut-Brain Axis (2019) · cites this paper as Thomas et al., 2009
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Bile acids also increase energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This effect is dependent on induction of the type 2 iodothyronine deiodinase and is mediated by the binding of bile acids to a novel G-protein-coupled receptor TGR5 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“Bile acids induce insulin secretion directly via the transmembrane bile acid receptor Takeda G protein–coupled receptor 5 (on β cells and indirectly via stimulation of l-cell derived GLP-1 and subsequent insulin release (110–112).”
From Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease (2018) · cites this paper as [112]
In the citing paper
“TGR5 is therefore a new and attractive target for treating obesity, since it can theoretically protect against obesity and its complications via two distinct and potentially synergistic mechanisms: increased energy expenditure and improved insulin sensitivity 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“Bile acids also increase energy expenditure in brown adipose tissue, preventing obesity and resistance to insulin. This effect is dependent on induction of the type 2 iodothyronine deiodinase and is mediated by the binding of bile acids to a novel G-protein-coupled receptor TGR5 148.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
In the citing paper
“One promising TGR5 agonist, INT-777, has already shown efficacy in vivo, increasing energy expenditure and reducing adiposity in mice with diet-induced obesity 148,149.”
From Cellular bioenergetics as a target for obesity therapy (2010) · cites this paper as [148]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220
Self-citationThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628
Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120
Hirasawa, A., Tsumaya, K., Awaji, T., Katsuma, S., Adachi, T., Yamada, M., Sugimoto, Y., Miyazaki, S., & Tsujimoto, G. (2004) · Nature Medicine · doi:10.1038/nm1168 · Cited by 1,580
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
渡辺, 光., Houten, S. M., Wang, L., Moschetta, A., Mangelsdorf, D. J., Heyman, R. A., Moore, D. D., & Auwerx, J. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21025 · Cited by 1,425
Self-citationTargeting bile‐acid signalling for metabolic diseases
Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., & Schoonjans, K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2619 · Cited by 1,422 · cited 2×
“The complete absence of changes in the expression level of classical target genes of FXR in the liver, such as cholesterol 7a hydroxylase (CYP7A1) and bile salt export pump (BSEP) (Thomas et al., 2008), further confirmed the specificity of INT-777 toward TGR5 (Figure S6B).”
BackgroundSelf-citationIdentification of membrane-type receptor for bile acids (M-BAR)
Maruyama, T., Miyamoto, Y., Nakamura, T., Tamai, Y., Okada, H., Sugiyama, E., Nakamura, T., Itadani, H., & Tanaka, K. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02550-0 · Cited by 993
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
Zhang, Y., Lee, F. Y., Barrera, G., Lee, H., Vales, C., Gonzalez, F. J., Willson, T. M., & Edwards, P. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506982103 · Cited by 974
Cited by
Sorted by citations
Items 901–999 of 999
Hepatoprotective impact of the bile acid receptor TGR5
Merlen, G., Bidault, V., Kahale, N., Glénisson, M., Bedoya, J. U., Doignon, I., Garcin, I., Humbert, L., Rainteau, D. P., & Tordjmann, T. (2020) · Liver International · doi:10.1111/liv.14427 · Cited by 29
Suga, T., Yamaguchi, H., Ogura, J., & Mano, N. (2019) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2019.03.003 · Cited by 32
Fuchs, S., Yusta, B., Baggio, L. L., Varin, E. M., Matthews, D., & Drucker, D. J. (2020) · JCI Insight · doi:10.1172/jci.insight.136907 · Cited by 29
TGR5 in the Cholangiociliopathies
Masyuk, T. V., Masyuk, A. I., & LaRusso, N. F. (2015) · Digestive Diseases · doi:10.1159/000371696 · Cited by 29
Microbial factors in inflammatory diseases and cancers
Ong, H. S., & Yim, H. C. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5987-2_7 · Cited by 29
Oleszycka, E., O’Brien, E. C., Freeley, M., Lavelle, E. C., & Long, A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1285357 · Cited by 29
Abiola, J. O., Oluyemi, A. A., Idowu, O. T., Oyinloye, O. M., Ubah, C. S., Owolabi, O. V., Somade, O. T., Onikanni, S. A., Ajiboye, B. O., Osunsanmi, F. O., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17060736 · Cited by 35
The Antidiabetic Potential of Probiotics: A Review
Li, S., Liu, Z., Zhang, Q., Su, D., Wang, P., Li, Y., Shi, W., & Zhang, Q. (2024) · Nutrients · doi:10.3390/nu16152494 · Cited by 30
Exposing 24-hour cycles in bile acids of male humans
Bello, A. T., Sarafian, M. H., Wimborne, E. A., Middleton, B., Revell, V. L., Raynaud, F. I., Chowdhury, N. R., van der Veen, D. R., Skene, D. J., & Swann, J. R. (2024) · Nature Communications · doi:10.1038/s41467-024-53673-9 · Cited by 32
Effect of anthocyanins on metabolic syndrome through interacting with gut microbiota
Du, L., Ding, X., Tian, Y., Chen, J., & Li, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107511 · Cited by 33
4-Benzofuranyloxynicotinamide derivatives are novel potent and orally available TGR5 agonists
Zou, Q., Duan, H., Ning, M., Liu, J., Feng, Y., Zhang, L., Zhu, J., Leng, Y., & Shen, J. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.031 · Cited by 31
Leva, F. S. D., Festa, C., Renga, B., Sepe, V., Novellino, E., Fiorucci, S., Zampella, A., & Limongelli, V. (2015) · Scientific Reports · doi:10.1038/srep16605 · Cited by 30
Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease
van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 31
Rao, J., Yang, C., Lu, H., Lu, H., Yang, S., Zhuang, L., Cheng, F., Zhang, F., Cheng, F., & Wang, X. (2018) · International Immunology · doi:10.1093/intimm/dxaa002 · Cited by 30
Does Gut-Microbiome Interaction Protect against Obesity and Obesity-Associated Metabolic Disorders?
Zawada, A. E., Rychter, A. M., Ratajczak, A. E., Lisiecka-Masian, A., Dobrowolska, A., & Krela‐Kaźmierczak, I. (2020) · Microorganisms · doi:10.3390/microorganisms9010018 · Cited by 29
TGR5 agonists for diabetes treatment: a patent review and clinical advancements (2012-present)
Bhimanwar, R. S., & Mittal, A. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2022.1994551 · Cited by 31
Varied Composition and Underlying Mechanisms of Gut Microbiome in Neuroinflammation
Farooq, R. K., Alamoudi, W., Alhibshi, A., Rehman, S., Sharma, A. R., & Abdulla, F. A. (2022) · Microorganisms · doi:10.3390/microorganisms10040705 · Cited by 31
Metabolic characterization of human intraocular fluid in patients with pathological myopia
Lian, P., Zhao, X., Song, H., Tanumiharjo, S., Chen, J., Wang, T., Chen, S., & Lü, L. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109184 · Cited by 29
Liver-derived metabolites as signaling molecules in fatty liver disease
Keles, U., Ow, J. R., Kuentzel, K. B., Zhao, L. N., & Kaldis, P. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04658-8 · Cited by 32
Polyunsaturated fatty acids-rich dietary lipid prevents high fat diet-induced obesity in mice
Haneishi, Y., Furuya, Y., Hasegawa, M., Takemae, H., Tanioka, Y., Mizutani, T., Rossi, M., & Miyamoto, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-32851-7 · Cited by 28
Bile acid effects are mediated by ATP release and purinergic signalling in exocrine pancreatic cells
Kowal, J. M., Haanes, K. A., Christensen, N. M., & Novak, I. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0107-9 · Cited by 29
Zheng, C., Zhou, W., Wang, T., You, P., Zhao, Y., Yang, Y., Wang, X., Luo, J., Chen, Y., Liu, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134051 · Cited by 30
Fabisiak, J. P., Medvedovic, M., Alexander, D. C., McDunn, J. E., Concel, V. J., Bein, K., Jang, A., Berndt, A., Vuga, L. J., Brant, K. A., et al. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100291 · Cited by 29
Nuclear receptors, bile acids and cholesterol homeostasis series – Bile acids and pregnancy
Abu‐Hayyeh, S., Papacleovoulou, G., & Williamson, C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.10.027 · Cited by 30
Adipocyte transdifferentiation and its molecular targets
Rajan, S., Gupta, A., Beg, M., Shankar, K., Srivastava, A., Varshney, S., Kumar, D., & Gaikwad, A. N. (2014) · Differentiation · doi:10.1016/j.diff.2014.07.002 · Cited by 29
Bile Acid Sequestrants: Glucose-Lowering Mechanisms
Prawitt, J., & Staels, B. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0096 · Cited by 30
Glucagon‐like peptide‐1: The missing link in the metabolic clock?
Brubaker, P. L., & Gil‐Lozano, M. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12477 · Cited by 29
Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay
Cheng, J., Cheng, K., Li, Y., Lo, S., Chang, C.-H., & Lee, K. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s113197 · Cited by 29
Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats
Lo, S., Li, Y., Cheng, K., Niu, C., Cheng, J., & Niu, H. (2017) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-017-1409-9 · Cited by 30
A pilot study of alternative substrates in the critically Ill subject using a ketogenic feed
McNelly, A. S., Langan, A., Bear, D. E., Page, A., Martin, T., Seidu, F., Santos, F., Rooney, K. D., Liang, K., Heales, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42659-8 · Cited by 28
Luo, Z., Zhou, W., Xie, T., Xu, W., Shi, C., Xiao, Z., Si, Y., Ma, Y., Ren, Q., Di, L., et al. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.04.027 · Cited by 31
Targeting the Gut Microbiota for Prevention and Management of Type 2 Diabetes
Zeppa, S. D., Gervasi, M., Bartolacci, A., Ferrini, F., Patti, A., Sestili, P., Stocchi, V., & Agostini, D. (2024) · Nutrients · doi:10.3390/nu16223951 · Cited by 33
The role of the gut hormone GLP-1 in the metabolic improvements caused by ileal transposition
Gaitonde, S. G., Kohli, R., & Seeley, R. J. (2011) · Journal of Surgical Research · doi:10.1016/j.jss.2011.04.044 · Cited by 28
Ipharraguerre, I. R., Tedó, G., Menoyo, D., Nuria, D. D. C., Holst, J. J., Nofrarías, M., Mereu, A., & Burrin, D. G. (2013) · Journal of Nutrition · doi:10.3945/jn.113.177865 · Cited by 28
Zhang, X., Wang, Y., Zhong, M., Liu, T., Han, H., Zhang, G., Liu, S., Wei, M., Wu, Q., & Hu, S. (2015) · Obesity Surgery · doi:10.1007/s11695-015-2031-x · Cited by 27
Dynamics of Bile Acid Profiles, GLP-1, and FGF19 After Laparoscopic Gastric Banding
Thöni, V., Pfister, A., Melmer, A., Enrich, B., Salzmann, K., Kaser, S., Lamina, C., Ebenbichler, C. F., Hackl, H., Tilg, H., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00235 · Cited by 29
Cardinelli, C. D. S., Torrinhas, R. S., Sala, P., Pudenzi, M. A., Angolini, C. F. F., da Silva, M. M., Machado, N. M., Ravacci, G. R., Eberlin, M. N., & Waitzberg, D. L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.028 · Cited by 28
Understanding connections and roles of gut microbiome in cardiovascular diseases
Rajendiran, E., Ramadass, B., & Ramprasath, V. R. (2020) · Canadian Journal of Microbiology · doi:10.1139/cjm-2020-0043 · Cited by 29
Lugiņina, J., Linden, M., Bazulis, M., Kumpiņš, V., Mishnev, A., Popov, S. A., Golubeva, T. S., Waldvogel, S. R., Shults, E. E., & Turks, M. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100293 · Cited by 28
Song, X., Zhu, Z., Qian, X., Liu, X., Chen, S., & Tang, H. (2022) · Molecules · doi:10.3390/molecules27061904 · Cited by 29
Redefining the TGR5 Triterpenoid Binding Pocket at the C‐3 Position
Genet, C., Schmidt, C., Strehle, A., Schoonjans, K., Auwerx, J. H., Saladin, R., & Wagner, A. (2010) · ChemMedChem · doi:10.1002/cmdc.201000329 · Cited by 28
Self-citationTaylor, D. R., Alaghband‐Zadeh, J., Cross, G. F., Omar, S., le Roux, C. W., & Vincent, R. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093540 · Cited by 28
Yu, X. X., Watts, L. M., Manchem, V. P., Chakravarty, K., Monia, B. P., McCaleb, M. L., & Bhanot, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066923 · Cited by 28
The Contributing Role of Bile Acids to Metabolic Improvements After Obesity and Metabolic Surgery
Fouladi, F., Mitchell, J. E., Wonderlich, J. A., & Steffen, K. J. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2272-3 · Cited by 29
Type 2 Diabetes and Bacteremia
Sato, J., Kanazawa, A., & Watada, H. (2017) · Annals of Nutrition and Metabolism · doi:10.1159/000479919 · Cited by 30
Haluzı́k, M., Kratochvílová, H., Haluzíková, D., & Mráz, M. (2018) · Journal of Endocrinology · doi:10.1530/joe-17-0438 · Cited by 30
Hofmann, A. F. (2010) · Hepatology · doi:10.1002/hep.24100 · Cited by 28
Wang, X., Zhao, D., Bi, D., Li, L., Tian, H., Yin, F., Zuo, T., Ianiro, G., Li, N., Chen, Q., et al. (2025) · 中国科学通报：英文版 · doi:10.1016/j.scib.2025.01.029 · Cited by 28
The role of gut microbiota in the pathogenesis of obesity and diabetes
Stachowicz, N., & Kiersztan, A. (2013) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/17322693.1044746 · Cited by 27
Zema, M. J. (2012) · Core evidence · doi:10.2147/ce.s26725 · Cited by 26
Differences in Weight Loss and Gut Hormones: Rouen-Y Gastric Bypass and Sleeve Gastrectomy Surgery
Malin, S. K., & Kashyap, S. R. (2015) · Current Obesity Reports · doi:10.1007/s13679-015-0151-1 · Cited by 28
Incretin Hormones: The Link between Glycemic Index and Cardiometabolic Diseases
Salvatore, T., Nevola, R., Pafundi, P. C., Monaco, L., Ricozzi, C., Imbriani, S., Rinaldi, L., & Sasso, F. C. (2019) · Nutrients · doi:10.3390/nu11081878 · Cited by 29
Tan, H., & Nie, S. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa065 · Cited by 27
The microbiota–gut–brain axis: A novel nutritional therapeutic target for growth retardation
Qi, M., Tan, B., Wang, J., Liao, S., Deng, Y., Ji, P., Song, T., Zha, A., & Yin, Y. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1879004 · Cited by 27
Zi, Z., & Rao, Y. (2024) · Science Advances · doi:10.1126/sciadv.adj0146 · Cited by 27
Nomilin as an Anti-Obesity and Anti-Hyperglycemic Agent
Sato, R. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00018-3 · Cited by 27
Updates in weight loss surgery and gastrointestinal peptides
Svane, M. S., Bojsen-Møller, K. N., Madsbad, S., & Holst, J. J. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000131 · Cited by 29
Mitochondria in response to nutrients and nutrient-sensitive pathways
Baltzer, C., Tiefenböck, S. K., & Frei, C. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.07.009 · Cited by 28
Morimoto, K., 渡辺, 光., Sugizaki, T., Irie, J., & Itoh, H. (2016) · Endocrinology · doi:10.1210/en.2015-1551 · Cited by 28
Chronic infusion of taurolithocholate into the brain increases fat oxidation in mice
Eggink, H. M., Tambyrajah, L. L., van den Berg, R., Mol, I. M., van den Heuvel, J. K., Koehorst, M., Groen, A. K., Boelen, A., Kalsbeek, A., Romijn, J. A., et al. (2017) · Journal of Endocrinology · doi:10.1530/joe-17-0503 · Cited by 31
Alteration in bile acids profile in large white pigs during chronic heat exposure
Fang, W., Wen, X., Meng, Q., Wu, W., Everaert, N., Xie, J., & Zhang, H. (2019) · Journal of Thermal Biology · doi:10.1016/j.jtherbio.2019.07.027 · Cited by 26
Araj‐Khodaei, M., Ayati, M. H., Azizi-Zeinalhajlou, A., Novinbahador, T., Yousefi, M., Shiri, M., Mahmoodpoor, A., Shamekh, A., Namazi, N., & Sanaie, S. (2023) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2023.2258559 · Cited by 30
Luo, Z., Du, Z., Huang, Y., Zhou, T., Wu, D., Yao, X., Shen, L., Yu, S., Yong, K., Wang, B., et al. (2024) · mSystems · doi:10.1128/msystems.00023-24 · Cited by 27
The bile–gut axis and metabolic consequences of cholecystectomy
Lange, A. H., Pedersen, M. G., Ellegaard, A., Nerild, H. H., Brønden, A., Sonne, D. P., & Knop, F. K. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae034 · Cited by 29
The Gut‒Liver Axis in Liver Disease: Molecular Mechanisms and Therapeutic Targets
Chen, Z., Liao, S., Wu, S., Chen, S., Tang, Q., Zhou, L., Li, X., Hu, H., Xu, J., Zhang, A., et al. (2025) · MedComm · doi:10.1002/mco2.70458 · Cited by 29
Inoue, T., Wang, J.-H., Higashiyama, M., Rudenkyy, S., Higuchi, K., Guth, P. H., Engel, E., Kaunitz, J. D., & Akiba, Y. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00195.2012 · Cited by 27
Targeting the gastrointestinal tract to treat type 2 diabetes
Bauer, P. V., & Duca, F. A. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0056 · Cited by 27
Patel, A. R., Yusta, B., Matthews, D., Charron, M. J., Seeley, R. J., & Drucker, D. J. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.06.006 · Cited by 25
Liu, L., Panzitt, K., Racedo, S., Wagner, M., Platzer, W., Zaufel, A., Theiler‐Schwetz, V., Obermayer-Pietsch, B. M., Müller, H., Höfler, G., et al. (2019) · Liver International · doi:10.1111/liv.14052 · Cited by 26
Kaya, D., Kaji, K., Tsuji, Y., Yamashita, S., Kitagawa, K., Ozutsumi, T., Fujinaga, Y., Takaya, H., Kawaratani, H., Moriya, K., et al. (2019) · Cells · doi:10.3390/cells8101153 · Cited by 26
Lucchinetti, E., Lou, P., Wawrzyniak, P., Wawrzyniak, M., Scharl, M. M., Holtzhauer, G., Krämer, S. D., Hersberger, M., Rogler, G., & Zaugg, M. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201901270 · Cited by 29
Recent advances in regulating cholesterol and bile acid metabolism
Sato, R. (2020) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2020.1793658 · Cited by 27
Zhang, X., Ren, H., Zhao, C., Shi, Z., Li, Q., Yang, F., Zhou, X., Han, X., Wu, K., Zhong, H., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05768-5 · Cited by 28
van Schaik, F. D. M., Gadaleta, R. M., Schaap, F. G., van Mil, S. W. C., Siersema, P. D., Oldenburg, B., & van Erpecum, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049706 · Cited by 25
Kida, T., Omori, K., Hori, M., Ozaki, H., & Murata, T. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.209288 · Cited by 27
Cholesteryl ester transfer protein protects against insulin resistance in obese female mice
Cappel, D. A., Palmisano, B. T., Emfinger, C. H., Martinez, M. N., McGuinness, O. P., & Stafford, J. M. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.08.007 · Cited by 27
Thibaut, M. M., Roumain, M., Piron, E., Gillard, J., Loriot, A. E., Neyrinck, A. M., Rodriguez, J., Massart, I. S., Thissen, J., Huot, J. R., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2449586 · Cited by 26
Ghebremariam, Y. T., Yamada, K., Lee, J. C., Johnson, C. L. C., Atzler, D., Anderssohn, M., Agrawal, R., Higgins, J., Patterson, A. J., Böger, R. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060653 · Cited by 26
Silva, V. D. O., Lobato, R. V., Andrade, E. F., Orlando, D. R., Borges, B. D. B., Zangerônimo, M. G., de Sousa, R., & Pereira, L. J. (2017) · Nutrients · doi:10.3390/nu9091016 · Cited by 25
Watanabe, K., Yamano, M., Masujima, Y., Ohue‐Kitano, R., & Kimura, I. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101095 · Cited by 25
A Bibliometric Analysis of Research on the Links Between Gut Microbiota and Atherosclerosis
Wang, Y., Li, D., Jia, Z., Hui, J., Xin, Q., Zhou, Q., Cong, W., & Xu, F. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.941607 · Cited by 25
Ge, Y., Zhang, L., Chen, W., Sun, M., Liu, W., & Li, X. (2023) · Antioxidants · doi:10.3390/antiox12010121 · Cited by 26
Noya-Leal, F., van der Wielen, N., Behrens, M., Rouschop, S. H., van Arkel, J., Jongsma, M. A., Witkamp, R. F., Mes, J. J., Bastiaan‐Net, S., & Meijerink, J. (2023) · Food & Function · doi:10.1039/d3fo00818e · Cited by 25
Zhang, M., Xiao, B., Chen, X., Ou, B., & Wang, S. (2023) · Acta Physiologica · doi:10.1111/apha.14065 · Cited by 28
Gut microbiota and type 2 diabetes mellitus: a focus on the gut-brain axis
Pan, Y., Bu, T., Deng, X., Jia, J., & Yuan, G. (2024) · Endocrine · doi:10.1007/s12020-023-03640-z · Cited by 28
Dietary resistant starch supplementation increases gut luminal deoxycholic acid abundance in mice
Reuter, M. A., Tucker, M., Marfori, Z., Shishani, R., Bustamante, J. M., Moreno, R., Goodson, M. L., Ehrlich, A. K., Taha, A. Y., Lein, P. J., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2315632 · Cited by 25
Molecular insights from bariatric surgery
Kohli, R., Stefater, M. A., & Inge, T. H. (2011) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-011-9172-6 · Cited by 24
Duodenal Chemosensing and Mucosal Defenses
Akiba, Y., & Kaunitz, J. D. (2011) · Digestion · doi:10.1159/000323401 · Cited by 25
Duodenal Luminal Chemosensing; Acid, ATP, and Nutrients
Akiba, Y., & Kaunitz, J. D. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990565 · Cited by 25
Ma, S.-Y., Ning, M., Zou, Q., Feng, Y., Ye, Y., Shen, J., & Leng, Y. (2016) · Acta Pharmacologica Sinica · doi:10.1038/aps.2016.27 · Cited by 24
Wang, S., Deng, Y., Xie, X., Ma, J., Xu, M., Zhao, X., Gu, W., Hong, J., Wang, W., Xu, G., et al. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12771 · Cited by 25
Ridge, E. A., Pachhain, S., Choudhury, S. R., Bodnar, S. R., Larsen, R. A., Phuntumart, V., & Sprague, J. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-40803-3 · Cited by 25
Deng, L., Chen, X., Zhong, Y., Wen, X., Cai, Y., Li, J., Fan, Z., & Feng, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6372786 · Cited by 26
Sasaki, T., Mita, M., Ikari, N., Kuboyama, A., Hashimoto, S., Kaneko, T., Ishiguro, M., Shimizu, M., Inoue, J., & Sato, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179226 · Cited by 25
Fasting and refeeding triggers specific changes in bile acid profiles and gut microbiota
Zhang, Y., Qi, H., Wang, L., Hu, C., Gao, A., Wu, Q., Wang, Q., Lin, H., Chen, B., Wang, X., et al. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13356 · Cited by 24
Bile salt signaling and bile salt-based therapies in cardiometabolic disease
Groenen, C., Nguyen, T.-A., Paulusma, C. C., & van de Graaf, S. F. J. (2024) · Clinical Science · doi:10.1042/cs20230934 · Cited by 25
The emerging role of the intestine in metabolic diseases
Bradley, W. D., Zwingelstein, C., & Rondinone, C. M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.578651 · Cited by 24
Amelioration of Endothelial Dysfunction in Diabetes: Role of Takeda G Protein–Coupled Receptor 5
Cai, Z., Yuan, S., Zhong, Y., Deng, L., Li, J., Tan, X., & Feng, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.637051 · Cited by 23
20-Hydroxyecdysone activates the protective arm of the renin angiotensin system via Mas receptor
Lafont, R., Raynal, S., Serova, M., Didry-Barca, B., Guibout, L., Latil, M., Dilda, P. J., Dioh, W., & Veillet, S. (2020) · doi:10.1101/2020.04.08.032607 · Cited by 11
Metadata
- Authors
- Thomas, C., Gioiello, A., Noriega, L., Strehle, A., Oury, J., Rizzo, G., Macchiarulo, A., Yamamoto, H., Mataki, C., Pruzanski, M., Pellicciari, R., Auwerx, J., & Schoonjans, K.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University of Perugia (IT)
- Intercept Pharmaceuticals (United States) (US)
- Corresponding author
- Auwerx, Johan
- Schoonjans, Kristina
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 10
- Issue
- 3
- Pages
- 167-177
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC2739652
- OpenAlex
- W2081271380
- Cited by
- 1,885
- References
- 43
- Citations by year
- 2026: 143 · 2025: 100 · 2024: 153 · 2023: 112 · 2022: 135 · 2021: 141 · 2020: 148 · 2019: 113 · 2018: 124 · 2017: 126 · 2016: 106 · 2015: 108 · 2014: 87 · 2013: 91 · 2012: 69
- FWCI
- 47.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1415 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- European Commission
- Centre National de la Recherche Scientifique
- Australian Research Council
- National Institutes of Health
- Agence Nationale de la Recherche
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Health Sciences › Nursing › Nutrition and Dietetics › Biochemical Analysis and Sensing Techniques
- Keywords
- TGR5, glucose homeostasis, glucagon-like peptide-1, enteroendocrine cells, energy expenditure, diet-induced obesity, diabesity, ATP/ADP ratio, calcium mobilization, brown adipose tissue, pancreatic function, liver function, TGR5 agonists, INT-777, incretin-based therapy
- MeSH terms
- Adenosine Triphosphate, Animals, Bile Acids and Salts, Calcium, Cell Line, Cholic Acids, Cricetulus, Glucose, Cricetinae, Homeostasis, Humans, Insulin, Male, Mice, Inbred C57BL, Mice, Obese, Oxidative Phosphorylation, Signal Transduction, CHO Cells, Mice, Knockout, Enteroendocrine Cells, Receptors, G-Protein-Coupled, Mice, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
